Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Naftopidil has effects on stromal and cancer cells

Jan. 19, 2011

Phase I/II trial of Mologen's MGN-1601 in renal cancer cleared to admit all patients

Jan. 18, 2011

Phase I trial to evaluate hydroxychloroquine to block autophagy in cancer

Jan. 18, 2011

Lorus Therapeutics begins phase I trial of anticancer candidate LOR-253

Jan. 18, 2011

MMRF and Synta Pharma to codevelop ganetespib for multiple myeloma

Jan. 18, 2011

MedImmune begins phase I MEDI-565 trial in gastrointestinal cancers

Jan. 17, 2011

ChemGenex notifies EMA of withdrawal of MAA for Tekinex for Ph+ CML

Jan. 17, 2011

SCV-07 advances in phase IIb trial for prevention of oral mucositis in head and neck cancer

Jan. 17, 2011

Threshold Pharma claims new camptothecin derivatives for cancer therapy

Jan. 17, 2011

CVA21 and doxorubicin demonstrate synergistic anticancer activity in vivo

Jan. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...